Published in Respir Res on July 14, 2007
Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) | NCT00268216
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study. BMC Pulm Med (2010) 0.84
Retrospective observations on the ability to diagnose and manage patients with asthma through the use of impulse oscillometry: comparison with spirometry and overview of the literature. Pulm Med (2014) 0.78
Validation of the ERS standard citric acid cough challenge in healthy adult volunteers. Cough (2010) 0.78
Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med (2001) 5.47
Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med (1992) 2.52
Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Respir J (1997) 1.98
A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol (2004) 1.45
Evaluation of impulse oscillation system: comparison with forced oscillation technique and body plethysmography. Eur Respir J (2001) 1.37
Clinical application of forced oscillation. Pulm Pharmacol Ther (2001) 1.36
Contribution of compliance of airways to frequency-dependent behavior of lungs. J Appl Physiol (1969) 1.35
Respiratory symptoms and physiologic assessment of ironworkers at the World Trade Center disaster site. Chest (2004) 1.35
Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax (1999) 1.34
Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J (1996) 1.33
Assessing change in airway calibre--measurement of airway resistance. Br J Clin Pharmacol (1979) 1.29
Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. J Allergy Clin Immunol (2001) 1.28
Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol (2002) 1.26
Assessment of reversibility of airflow obstruction. Am J Respir Crit Care Med (1994) 1.25
A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. Eur Respir J (1992) 1.24
Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. Thorax (1993) 1.22
A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma. Br J Clin Pharmacol (2005) 1.03
Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD. Eur Respir J (1998) 1.00
Respiratory system reactance as an indicator of the intrathoracic airway response to methacholine in children. Pediatr Pulmonol (1996) 0.99
Forced oscillation techniques for measuring mechanical properties of the respiratory system. Thorax (1992) 0.94
Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Respir Med (2003) 0.93
Total respiratory resistance and reactance in patients with asthma, chronic bronchitis, and emphysema. Am Rev Respir Dis (1991) 0.92
Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med (2005) 0.86
Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am J Med (2005) 0.86
Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness. Chest (2002) 0.83
Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. Br J Clin Pharmacol (2003) 0.83
Frequency dependence of compliance in the evaluation of patients with unexplained respiratory symptoms. Respir Med (2000) 0.82
A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest (2002) 2.74
Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet (2006) 2.63
Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med (2003) 2.45
Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med (2006) 2.41
The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc Natl Acad Sci U S A (2011) 2.38
Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ (2002) 2.14
Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids. Ann Allergy Asthma Immunol (2012) 1.97
Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol (2010) 1.84
Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med (2004) 1.66
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Respir Med (2006) 1.65
Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.64
Lung function at age 3 years: effect of pet ownership and exposure to indoor allergens. Arch Pediatr Adolesc Med (2004) 1.59
IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol (2005) 1.58
Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial. Respir Med (2012) 1.57
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol (2007) 1.53
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. Int J Chron Obstruct Pulmon Dis (2012) 1.52
Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. Int J Chron Obstruct Pulmon Dis (2010) 1.51
Increased airway T regulatory cells in asthmatic subjects. Chest (2010) 1.50
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. Eur Respir J (2012) 1.50
Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology (2010) 1.49
A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol (2004) 1.45
The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr Allergy Immunol (2002) 1.43
Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure. PLoS Med (2008) 1.43
High-efficiency particulate arrest-filter vacuum cleaners increase personal cat allergen exposure in homes with cats. J Allergy Clin Immunol (2003) 1.42
Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med (2005) 1.40
Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol (2004) 1.37
Exercise-induced bronchospasm and atopy in Ghana: two surveys ten years apart. PLoS Med (2007) 1.37
24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids. Eur Respir J (2012) 1.36
Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol (2006) 1.28
Exposure and sensitization to indoor allergens: association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma. J Allergy Clin Immunol (2003) 1.28
MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.27
CD4-regulatory cells in COPD patients. Chest (2007) 1.27
Specific airway resistance in 3-year-old children: a prospective cohort study. Lancet (2002) 1.25
alpha,beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol (2009) 1.24
Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am J Respir Crit Care Med (2007) 1.22
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma. Eur Respir J (2013) 1.20
Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med (2008) 1.19
Safety of indacaterol in the treatment of patients with COPD. Int J Chron Obstruct Pulmon Dis (2011) 1.19
The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest (2003) 1.16
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11
Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One (2011) 1.11
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. BMC Pulm Med (2010) 1.10
Tobacco smoke exposure, wheeze, and atopy. Pediatr Pulmonol (2004) 1.09
Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. Ann Allergy Asthma Immunol (2003) 1.08
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. Thorax (2013) 1.08
The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD. Br J Clin Pharmacol (2008) 1.06
Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med (2009) 1.06
Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments. Chest (2006) 1.05
Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor. J Endocrinol (2008) 1.05
The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD. Eur Respir J (2013) 1.04
Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol (2007) 1.04
Impact factor and its role in academic promotion. Int J Chron Obstruct Pulmon Dis (2009) 1.04
Asthma and sensitization in a community with low indoor allergen levels and low pet-keeping frequency. J Allergy Clin Immunol (2004) 1.04
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs. Eur Respir J (2012) 1.02
Chronic cough: relationship between microaspiration, gastroesophageal reflux, and cough frequency. Chest (2012) 1.01
Current mite, cat, and dog allergen exposure, pet ownership, and sensitization to inhalant allergens in adults. J Allergy Clin Immunol (2003) 0.99
New developments in the objective assessment of cough. Lung (2007) 0.98
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells. Am J Physiol Lung Cell Mol Physiol (2012) 0.98
The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis (2009) 0.98
Exhaled breath condensate pH and childhood asthma: unselected birth cohort study. Am J Respir Crit Care Med (2006) 0.98
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease. Respir Res (2012) 0.97
COPD phenotype description using principal components analysis. Respir Res (2009) 0.97
A qualitative exploration of treatment decision-making role preference in adult asthma patients. Health Expect (2002) 0.97
Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax (2011) 0.97
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine (2008) 0.95
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. Respir Res (2007) 0.95
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95
Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 0.94
Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst (2010) 0.93
Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. J Pharmacol Exp Ther (2013) 0.93
A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir Med (2006) 0.92
Effect of day care attendance on sensitization and atopic wheezing differs by Toll-like receptor 2 genotype in 2 population-based birth cohort studies. J Allergy Clin Immunol (2011) 0.92
Gabapentin for refractory chronic cough. Lancet (2013) 0.92
LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. Int Immunopharmacol (2012) 0.91
Array-based diagnostic gene-expression score for atopy and asthma. J Allergy Clin Immunol (2002) 0.90
An exploratory study of priority information needs in adult asthma patients. Patient Educ Couns (2002) 0.89
Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells. PLoS One (2011) 0.89
Day-care attendance, position in sibship, and early childhood wheezing: a population-based birth cohort study. J Allergy Clin Immunol (2008) 0.88
Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol (2012) 0.88
New developments in reflux-associated cough. Lung (2009) 0.88
Dimensions of respiratory symptoms in preschool children: population-based birth cohort study. Am J Respir Crit Care Med (2008) 0.88
The effects of dexamethasone on cigarette smoke induced gene expression changes in COPD macrophages. Int Immunopharmacol (2009) 0.87
Cough and its importance in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.87
Reduced glucocorticoid receptor expression and function in airway neutrophils. Int Immunopharmacol (2011) 0.87
MR Quantitative Equilibrium Signal Mapping: A Reliable Alternative to CT in the Assessment of Emphysema in Patients with Chronic Obstructive Pulmonary Disease. Radiology (2015) 0.86
Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients. Respir Res (2006) 0.86
Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate. PLoS One (2013) 0.86
Behavior problems antecede the development of wheeze in childhood: a birth cohort study. Am J Respir Crit Care Med (2004) 0.86
Staphylococcus aureus sensitization and allergic disease in early childhood: population-based birth cohort study. J Allergy Clin Immunol (2007) 0.85
Down regulation of T cell receptor expression in COPD pulmonary CD8 cells. PLoS One (2013) 0.84